FDA: Zephyr Endobronchial Valve approved for severe emphysema

July 8, 2018

(HealthDay)—A new device, the Zephyr Endobronchial Valve (Zephyr Valve), has been approved by the U.S. Food and Drug Administration for the treatment of breathing difficulties associated with severe emphysema.

During a procedure in a hospital setting, the Zephyr Valves are placed into the diseased areas of the lung airways using a flexible bronchoscope. The is designed to prevent air from entering the damaged parts of the lung and allow the escape of trapped air and fluids.

Data were reviewed from a multicenter study of 190 patients with . A total of 128 patients were treated with Zephyr Valves and medical management, including medications and pulmonary rehabilitation, while the (62 patients) received alone. At one year, 47.7 percent of patients treated with the Zephyr Valves and 16.8 percent of the control group experienced at least a 15 percent improvement in their pulmonary function scores. Approval for the device was granted to Pulmonx.

"Treatment options are limited for people with emphysema who have severe symptoms that have not improved from taking medicines," Tina Kiang, Ph.D., acting director of the Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices in the FDA's Center for Devices and Radiological Health, said in a statement. "This novel device is a less invasive treatment that expands the options available to patients."

Explore further: Trial demonstrates effectiveness of minimally invasive emphysema treatment

More information: More Information

Related Stories

Trial demonstrates effectiveness of minimally invasive emphysema treatment

May 22, 2018
For patients with severe emphysema, every breath brings equal parts relief and burden. Oxygenated air comes in, but not all the air from the last breath is exhaled. Rather, it becomes trapped in the lungs, caught in large ...

Endobronchial valve treatment appears to improve lung function in patients with severe emphysema

September 8, 2017
People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a randomized, controlled trial published online ...

One-way valves to treat severe emphysema

April 14, 2015
Investigators at the University of Alabama at Birmingham are investigating whether a one-way valve placed in the lungs of patients with severe emphysema will help improve lung function. It is one of several techniques being ...

Endobronchial valves can improve lung physiology

September 8, 2016
(HealthDay)—Use of endobronchial valves (EBV) can improve lung physiology in patients with homogeneous emphysema with absence of collateral ventilation, according to a study published online Aug. 31 in the American Journal ...

Interlobar collateral ventilation impacts EB valve outcomes

December 10, 2015
(HealthDay)—A more careful selection of patients could help improve the success rate of bronchoscopic lung-volume reduction with the use of one-way endobronchial valves in patients with emphysema, according to a study published ...

FDA approves mechanical heart valve for newborns

March 7, 2018
(HealthDay)—The U.S. Food and Drug Administration has approved the world's smallest mechanical heart valve, designed to be used in newborns and other young infants with heart defects.

Recommended for you

Southern diet could be deadly for people with heart disease

July 12, 2018
People with a history of heart disease who eat a traditional Southern diet are more likely to die than those who follow a Mediterranean dietary pattern, according to new research.

Late-life high blood pressure may harm the brain, study says

July 11, 2018
Decades ago, hundreds of nuns and priests made an extraordinary decision: They agreed to donate their brains upon death to science, hoping to help solve mysteries about Alzheimer's and other diseases. Now, a study that used ...

Multivitamins do not promote cardiovascular health

July 10, 2018
Taking multivitamin and mineral supplements does not prevent heart attacks, strokes or cardiovascular death, according to a new analysis of 18 studies published in Circulation: Cardiovascular Quality and Outcomes, an American ...

Mobile health devices diagnose hidden heart condition in at-risk populations

July 10, 2018
Wearable mobile health devices improved the rate of diagnosis of a dangerous and often hidden heart condition called atrial fibrillation (AFib), according to a first of its kind, home-based clinical study conducted in part ...

Chronic heart disease poses high financial burden to low-income families

July 3, 2018
The financial burdens of long-term care for a family member with atherosclerotic cardiovascular disease (ASCVD) disproportionately affect low-income American families, even those who have insurance, found researchers at Yale ...

Women with high blood pressure during pregnancy more likely to develop CVD risk factors

July 2, 2018
Preeclampsia and gestational hypertension are common pregnancy complications involving high blood pressure that develops for the first time during pregnancy and returns to normal after delivery. Previous studies have shown ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.